62 related articles for article (PubMed ID: 23360272)
21. A phase I/IIa clinical trial of a recombinant Rho protein antagonist in acute spinal cord injury.
Fehlings MG; Theodore N; Harrop J; Maurais G; Kuntz C; Shaffrey CI; Kwon BK; Chapman J; Yee A; Tighe A; McKerracher L
J Neurotrauma; 2011 May; 28(5):787-96. PubMed ID: 21381984
[TBL] [Abstract][Full Text] [Related]
22. Rho Inhibitor VX-210 in Acute Traumatic Subaxial Cervical Spinal Cord Injury: Design of the SPinal Cord Injury Rho INhibition InvestiGation (SPRING) Clinical Trial.
Fehlings MG; Kim KD; Aarabi B; Rizzo M; Bond LM; McKerracher L; Vaccaro AR; Okonkwo DO
J Neurotrauma; 2018 May; 35(9):1049-1056. PubMed ID: 29316845
[TBL] [Abstract][Full Text] [Related]
23. Rho signaling pathway targeted to promote spinal cord repair.
Dergham P; Ellezam B; Essagian C; Avedissian H; Lubell WD; McKerracher L
J Neurosci; 2002 Aug; 22(15):6570-7. PubMed ID: 12151536
[TBL] [Abstract][Full Text] [Related]
24. Combined application of Rho-ROCKII and GSK-3β inhibitors exerts an improved protective effect on axonal regeneration in rats with spinal cord injury.
Zhang G; Lei F; Zhou Q; Feng D; Bai Y
Mol Med Rep; 2016 Dec; 14(6):5180-5188. PubMed ID: 27840930
[TBL] [Abstract][Full Text] [Related]
25. Rho as a target to promote repair: translation to clinical studies with cethrin.
McKerracher L; Guertin P
Curr Pharm Des; 2013; 19(24):4400-10. PubMed ID: 23360272
[TBL] [Abstract][Full Text] [Related]
26. Rho-ROCK inhibition in the treatment of spinal cord injury.
Forgione N; Fehlings MG
World Neurosurg; 2014; 82(3-4):e535-9. PubMed ID: 23298675
[TBL] [Abstract][Full Text] [Related]
27. Spinal cord injury and neural repair: focus on neuroregenerative approaches for spinal cord injury.
Baptiste DC; Tighe A; Fehlings MG
Expert Opin Investig Drugs; 2009 May; 18(5):663-73. PubMed ID: 19379122
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic effects of Clostridium botulinum C3 exoenzyme.
Just I; Rohrbeck A; Huelsenbeck SC; Hoeltje M
Naunyn Schmiedebergs Arch Pharmacol; 2011 Mar; 383(3):247-52. PubMed ID: 21193903
[TBL] [Abstract][Full Text] [Related]
29. Targeting Rho to stimulate repair after spinal cord injury.
McKerracher L; Higuchi H
J Neurotrauma; 2006; 23(3-4):309-17. PubMed ID: 16629618
[TBL] [Abstract][Full Text] [Related]
30. Rho signaling and axon regeneration.
McKerracher L; Ferraro GB; Fournier AE
Int Rev Neurobiol; 2012; 105():117-40. PubMed ID: 23206598
[TBL] [Abstract][Full Text] [Related]
31. Inactivation of intracellular Rho to stimulate axon growth and regeneration.
Ellezam B; Dubreuil C; Winton M; Loy L; Dergham P; Sellés-Navarro I; McKerracher L
Prog Brain Res; 2002; 137():371-80. PubMed ID: 12440379
[TBL] [Abstract][Full Text] [Related]
32. Mevalonate Cascade and Small Rho GTPase in Spinal Cord Injury.
Eftekharpour E; Nagakannan P; Iqbal MA; Chen QM
Curr Mol Pharmacol; 2017; 10(2):141-151. PubMed ID: 26758952
[TBL] [Abstract][Full Text] [Related]
33. Rho-ROCK inhibitors as emerging strategies to promote nerve regeneration.
Kubo T; Hata K; Yamaguchi A; Yamashita T
Curr Pharm Des; 2007; 13(24):2493-9. PubMed ID: 17692017
[TBL] [Abstract][Full Text] [Related]
34. Clostridial C3 proteins: recent approaches to improve neuronal growth and regeneration.
Höltje M; Just I; Ahnert-Hilger G
Ann Anat; 2011 Jul; 193(4):314-20. PubMed ID: 21459564
[TBL] [Abstract][Full Text] [Related]
35. Pharmacological approaches to induce neuroregeneration in spinal cord injury: an overview.
Ibarra A; Martiñón S
Curr Drug Discov Technol; 2009 Jun; 6(2):82-90. PubMed ID: 19519335
[TBL] [Abstract][Full Text] [Related]
36. Strategies to neutralize RhoA/ROCK pathway after spinal cord injury.
Roy A; Pathak Z; Kumar H
Exp Neurol; 2021 Sep; 343():113794. PubMed ID: 34166685
[TBL] [Abstract][Full Text] [Related]
37. Granulocyte Colony-Stimulating Factor (G-CSF) for the Treatment of Spinal Cord Injury.
Khorasanizadeh M; Eskian M; Vaccaro AR; Rahimi-Movaghar V
CNS Drugs; 2017 Nov; 31(11):911-937. PubMed ID: 29063471
[TBL] [Abstract][Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
